LoDoCo2: Added Steam for Colchicine as Secondary Prevention
1 Sep 2020
Medscape
The anti-inflammatory drug colchicine picked up new support as secondary prevention in chronic coronary disease, cutting the risk of cardiovascular events by one third when added to standard prevention therapies in the double-blind LoDoCo2 study.